BACKGROUND: Variants in RCBTB1 were recently described to cause a retinal dystrophy with only eight families described to date and a predominant phenotype of macular atrophy and peripheral reticular degeneration. Here, we further evaluate the genotypic and phenotypic characteristics of biallelic RCBTB1-associated retinal dystrophy in a North American clinic population. METHODS: A retrospective analysis of genetic and clinical features was performed in individuals with biallelic variants in RCBTB1. RESULTS: Three unrelated individuals of French-Canadian descent with rare biallelic RCBTB1 variants were identified. All individuals shared a novel p.(Ser342Leu) missense variant; one patient was homozygous whereas the other two each possessed a second unique novel variant p.(Gln120*) and p.(Pro224Leu). All three had macula-predominant disease with symptom onset in the fifth decade of life. CONCLUSION: This report adds to the genetic diversity of RCBTB1-associated disease. These cases confirm the later-onset, relative to many other retinal dystrophies, and macular focus of disease described in most cases to-date. They are thus a reminder of considering hereditary disease in the differential for later-onset macular atrophy.
BACKGROUND: Variants in RCBTB1 were recently described to cause a retinal dystrophy with only eight families described to date and a predominant phenotype of macular atrophy and peripheral reticular degeneration. Here, we further evaluate the genotypic and phenotypic characteristics of biallelic RCBTB1-associated retinal dystrophy in a North American clinic population. METHODS: A retrospective analysis of genetic and clinical features was performed in individuals with biallelic variants in RCBTB1. RESULTS: Three unrelated individuals of French-Canadian descent with rare biallelic RCBTB1 variants were identified. All individuals shared a novel p.(Ser342Leu) missense variant; one patient was homozygous whereas the other two each possessed a second unique novel variant p.(Gln120*) and p.(Pro224Leu). All three had macula-predominant disease with symptom onset in the fifth decade of life. CONCLUSION: This report adds to the genetic diversity of RCBTB1-associated disease. These cases confirm the later-onset, relative to many other retinal dystrophies, and macular focus of disease described in most cases to-date. They are thus a reminder of considering hereditary disease in the differential for later-onset macular atrophy.
Authors: Zhiqin Huang; Dan Zhang; Shang-Chih Chen; Jennifer A Thompson; Terri McLaren; Tina Lamey; John N De Roach; Samuel McLenachan; Fred K Chen Journal: Stem Cell Res Date: 2019-08-23 Impact factor: 2.020
Authors: Vasileios Soumplis; Panagiotis I Sergouniotis; Anthony G Robson; Michel Michaelides; Anthony T Moore; Graham E Holder; Andrew R Webster Journal: Acta Ophthalmol Date: 2013-01-07 Impact factor: 3.761
Authors: Zhiqin Huang; Dan Zhang; Jennifer A Thompson; Saumya S Jamuar; Danial Roshandel; Luke Jennings; Carla Mellough; Jason Charng; Shang-Chih Chen; Terri L McLaren; Tina M Lamey; Enid Chelva; John N De Roach; Choi Mun Chan; Samuel McLenachan; Fred K Chen Journal: Ophthalmic Genet Date: 2021-02-24 Impact factor: 1.803
Authors: Frauke Coppieters; Giulia Ascari; Katharina Dannhausen; Konstantinos Nikopoulos; Frank Peelman; Marcus Karlstetter; Mingchu Xu; Cécile Brachet; Isabelle Meunier; Miltiadis K Tsilimbaris; Chrysanthi Tsika; Styliani V Blazaki; Sarah Vergult; Pietro Farinelli; Thalia Van Laethem; Miriam Bauwens; Marieke De Bruyne; Rui Chen; Thomas Langmann; Ruifang Sui; Françoise Meire; Carlo Rivolta; Christian P Hamel; Bart P Leroy; Elfride De Baere Journal: Am J Hum Genet Date: 2016-08-04 Impact factor: 11.025
Authors: Zhiqin Huang; Dan Zhang; Shang-Chih Chen; Luke Jennings; Livia S Carvalho; Sue Fletcher; Fred K Chen; Samuel McLenachan Journal: J Cell Mol Med Date: 2021-10-07 Impact factor: 5.310
Authors: Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur Journal: Nature Date: 2020-05-27 Impact factor: 69.504